We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Helping Stutterers Speak Freely

By Biotechdaily staff writers
Posted on 14 Feb 2007
A new device can aid stutterers speak more clearly, just as eyeglasses improve vision. More...
The SpeechEasy fluency device is worn like a hearing aid and uses a system of altered auditory feedback (AAF) to help alleviate stuttering.

When someone wearing the device speaks, their words are digitally replayed in their ear with a very slight delay and frequency modification. As a result, the brain perceives that it is speaking in unison with another person. This perception of speaking in unison creates the so-called choral effect, a phenomenon in which stutterers do not stutter when speaking the same material in unison with another speaker, or in a chorus. For best results, it is recommended that a speech pathologist determine who is a proper candidate for a fluency device, as well as what therapies and techniques will enhance the device's success. The SpeechEasy is a product of the Janus Development Group (Greenville, NC, USA).

"This is the beginning of the new era for the person who stutters,” said SpeechEasy developer Joseph Kalinowski, a stutterer himself and a speech pathologist at East Carolina University (Greenfield, NC, USA).

Stuttering is considered a medical mystery, but there is some indication that genetic factors are involved in the development of stuttering and subsequent recovery, as shown by various studies done on families and twins. It is not known to what degree stuttering is dependent on genetic factors, on environmental factors, or on both.


Related Links:
SpeechEasy
East Carolina University

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Pipette Calibration System
Artel PCS®
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.